Databricks launches AiChemy multi-agent AI for drug discovery

Databricks has outlined a reference architecture for a multi-agent AI system, named AiChemy, that combines internal enterprise data on its platform with external scientific databases via the Model Context Protocol (MCP) to accelerate drug discovery tasks such as target identification and candidate evaluation. These early-stage steps are critical in drug development because they help pharma companies determine which biological mechanisms to pursue and which compounds are worth advancing, direc...